Nicole Dale

Pharma Writer, Pharmatica
  • South Africa
  • Joined 2026
3 Followers
2 Following

About

Nicole (BSc Molecular Medicine, Honours Medical Biochemistry) has many years of pharmaceutical experience, having worked for top CROs and biopharma companies for more than a decade.

Areas of Expertise

Published content

    • Decentralised Clinical Trials
    • Clinical Trial Design
    • Clinical Trial Regulation
    • Clinical Data
    • Patient Centricity and Outcomes
    • Patient Enrolment
    • Pharma Regulation
    • Pharma Policy
    • HTA and Reimbursement
    • Post-market
    • RWE Strategy
    • Clinical Outcomes
    • Remote Clinical Monitoring
    • Digital Health
    • Data and Digital Health

    Designing Decentralised Clinical Trials for Patient Diversity

    • Drug Discovery
    • Oncology
    • Precision Medicine
    • Translational Science and Biomarkers
    • Preclinical Development
    • Biomedical R&D
    • Patient Centricity and Outcomes
    • Clinical Outcomes
    • Patient Enrolment
    • Biostatistics
    • Diagnostics
    • Clinical Trial Design
    • AI Drug Discovery
    • AI Drug Development
    • Multiomics
    • AI in Clinical Trials
    • Next-gen Modalities
    • Cell and Gene Therapy
    • Tech and Innovation
    • Immunology and Immunotherapy
    • Small Molecules
    • Drug Delivery
    • RWE Strategy
    • Decentralised Clinical Trials
    • Adaptive Clinical Trials
    • Pricing and Market Access

    Why Precision Alone Isn't Enough in Oncology Drug Discovery

    • RWE Strategy
    • Clinical Outcomes
    • Clinical Data
    • Post-market
    • Pharma Policy
    • Pharma Regulation
    • HTA and Reimbursement
    • Pricing and Market Access
    • Medical Devices
    • Electronic Data Capture
    • Wearables
    • Data and Digital Health
    • Patient Centricity and Outcomes
    • AI and Automation
    • Rare Diseases
    • Orphan Drugs
    • Biostatistics
    • Patient Enrolment

    Select the Right Data Collection Method for Real-World Evidence

    • Drug Discovery
    • AI Drug Discovery
    • AI Drug Development
    • Multiomics
    • HTS and Automation
    • Biomedical R&D
    • Preclinical Development
    • Investment and Market Analysis
    • Tech and Innovation
    • AI & Machine Learning
    • Pharma Policy
    • Pharma Regulation
    • Patient Centricity and Outcomes
    • Pharmacology
    • Rare Diseases
    • Infectious Diseases and Vaccines
    • Translational Science and Biomarkers

    Drug Discovery and Pharmacoinformatics in 2026